Drug-protein adducts:an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development .Characterization of novel glutathione adducts of a non-nucleosidereverse transcriptase inhibitor,6-chloro-4-(cyclopropylethinyl)-4-trifluoromethyl-3, 4-dihydro-2(1H)-quinazolinone(DP-961),in rats .Beiley MJ, Dickinson RG . Limitations of hepatocytes and liver homogenates in modeling in vivo formation of acyl glucuronide-derived drug-protein adducts .
……